Description
AC-262 research SARM
AC-262 (AC-262,536) is a non-steroidal SARM described as a partial agonist of the androgen receptor, studied in preclinical models.
Product details
| Compound | AC-262 (AC-262,536, Accadrine) |
|---|---|
| Class | Selective androgen receptor modulator |
| Form | Capsules; Liquid; Powder |
| Strength | 20mg per capsule/60ct/1.2g; 15ml/17mg per ml/250mg; 30ml/33mg per ml/1000mg; 500mg; 1000mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What research has examined
- Partial agonism: androgen receptor activity in rat models.
- Tissue selectivity: muscle versus prostate endpoints.
- Analogue research: comparison with other non-steroidal SARMs.
Learn more in What are SARMs?
Regulatory status
This compound is not an approved medicine. The FDA has warned about serious risks from products containing SARMs and similar compounds, and these compounds are prohibited in sport by WADA. Supplied as a research chemical only.
Storage and handling
Keep the container tightly closed, at room temperature or cooler, away from moisture and light.
Related research products
Andarine (S-4) · RAD 140 (Testolone) · RAD-150 (TLB 150) · All SARMs
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.